January 15, 2024
2 min watch
Save
VIDEO: Sydnexis to debut data for progressive pediatric myopia treatment in 2024
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
WAILEA, Hawaii — In this Healio video perspective from Hawaiian Eye 2024, Nick Ruth, MBA, of Sydnexis, delivers an update on SYD-101, the company’s upcoming treatment for progressive myopia in pediatric patients.
The company plans to unmask data for the eye drop in the second quarter of 2024.
Ruth also highlights recent developments in the larger space of pediatric myopia, including the ways in which large technology companies are getting involved.
“Big tech is involved, we’re working on a treatment with a highly differentiated formulation and everything’s starting to move in the right direction,” Ruth said.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Ruth reports being the chief commercial officer of Sydnexis.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.